News
Evolution of severely immunosuppressed HIV patients depends on the immunologic and virologic response to treatment, regardless of the initial state
So far only it takes into account the baseline of the patients The study concludes that in spite that even in the worst scenario the patient may control the virus, treatment should begin from the time of diagnosis More than half of patients arrive late to treatment Article reference
UB, IDIBELL and the company FCTecnics collaborate on a project to develop a technology that allows advance the research of neurodegenerative d
The invention is an extensometer designed for researchers to conduct experiments of mechanical stress with large biological structures, such as nerves, tendons, muscles, in the search for neurodegenerative diseases such as Charcot-Marie -tooth.The project by the research group of Dr. Carlos Solsona, professor of the Department of Pathology and Experimental Therapeutics at the University of […]
La Marató de TV3 funds five projects of IDIBELL and CMRB
La Marató de TV3 Foundation, which just a year ago was dedicated to raise funds for research into heart disease, will finance three research projects of the Bellvitge Biomedical Research Institute (IDIBELL), and two of the Center for Regenerative Medicine of Catalonia (CMRB). The ceremony took place on November 5, at the Academy of Medical […]
Researchers create a worm model to investigate a rare subtype of blindness
Local mutations, overall pathology Worms avatar Reference
Precipita platform raises funds for research in Cornelia de Lange syndrome at IDIBELL
The Cornelia de Lange Syndrome (CDLS) is a very rare disease characterized by severe mental and growth retardation, and a characteristic facial dimorphism. In severe cases, there is total or partial absence of the upper limbs and psychomotor deficits have so often come to not walk. Researchers of the Cell cycle research group at the […]
Researchers identify molecules with potential therapeutic use as immunosuppressive agents
Researchers from the Human Molecular Genetics at IDIBELL, led by Mercè Pérez, of the Autonomous University of Barcelona and the CIMA Clinic of Navarra, has identified two small organic compounds that compete with NFATc to join in the same place calcineurin protein and that could have a potential immunosuppressive effect. Activation of the immune response […]